← Leaderboards
Bhawanjit K Brar
Jaan Biotherapeutics, Inc.
$1,020,224
Attributed
$2,129,173
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,129,173 · 4
By mechanism
R44$1,290,338 · 1
R43$613,835 · 2
R41$225,000 · 1
Top collaborators
- Kirk Peterson3 shared
- Keith James Jenne2 shared
- Ghassan S Kassab1 shared
Most similar at Jaan Biotherapeutics, Inc.
Same institution · by research overlap
- Keith James Jenne$537,141
Others in their field
Other Emerging Leaders on “Investigational New Drug Application”
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$46,710,255
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Xinhua Li · Nano Terra, Inc.$27,970,096
- Kathleen Maletic Neuzil · Emory University$27,203,974
- Sujatha Rashid · American Type Culture Collection$10,735,388
- Bronwen Shaw · Medical College Of Wisconsin$10,328,749
Research focus
Investigational New Drug ApplicationLegal PatentFailureInnovationIschemiaDeteriorationCause Of DeathCoronaryCicatrixHeart FunctionHeartHeart FailureDesignCardiacAdultBiological Response Modifier TherapyCardiac MyocytesCardiac RegenerationAcuteCessation Of LifeClinically RelevantBlood FlowDependovirusMammals
Grant awards (5)
Heart Muscle Regeneration$1,290,338
R44 · FY2025 · HL · contact PI
VIRAL DELIVERED CARDIAC REGENERATION$52,000
R43 · FY2021 · HL · contact PI
VIRAL DELIVERED CARDIAC REGENERATION$321,085
R43 · FY2020 · HL · contact PI
MicroRNA Inhibition for Cardiac Regeneration in Ischemia$240,750
R43 · FY2017 · HL · contact PI
Oligonucleotide Inhibition for cardiac regeneration in Ischemia$225,000
R41 · FY2017 · HL · contact PI